Impacted lower mandibular molars Oral Health
Conditions
Interventions
Participants were randomly divided by block randomization to receive 2% lidocaine or 0.5% bupivacaine post-operatively. Either molar side was randomly selected for the initial surgery and flushed with
Sponsors
Chiang Mai University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 25 years 2. Systemically deemed to be healthy 3. Orthodontically indicated for impacted lower third molar on both sides as depicted in panoramic radiographs 4. Non-allergic to amoxicillin and paracetamol 5. Had not previously experienced inflammation or infection of the teeth and gums around the lower molars before treatment
Exclusion criteria
Exclusion criteria: 1. History of neurological disorders 2. Allergies to lidocaine and bupivacaine 3. Received steroid medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Duration of surgery and postoperative irrigation volume of NSS or lidocaine plus epinephrine used, recorded after surgery 2. Pain is measured using the visual analogue score (VAS) at baseline, 24, 48 and 72 hours 3. Number of paracetamol consumed, recorded after surgery 4. VAS-aided assessment of pain measured in participants receiving bupivacaine or lidocaine at 2, 4, 6, and 8 hours post-operation | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Thailand
Contacts
Public ContactSomdet Srichairatanakool
Outcome results
None listed